158 related articles for article (PubMed ID: 38090517)
1. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
[TBL] [Abstract][Full Text] [Related]
2. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
4. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
5. The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
Li R; Li Z; Yang Z; Qiu B; Tan F; Xue Q; Gao S; He J
Transl Lung Cancer Res; 2024 Feb; 13(2):256-268. PubMed ID: 38496684
[TBL] [Abstract][Full Text] [Related]
6. [The correlation study of ground glass opacity and lepidic growth pattern component in stage I lung invasive adenocarcinoma].
Zhang L; Wu N; Li M; Sun W; Lyu L; Hou DH; Lin DM
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):269-273. PubMed ID: 28550666
[No Abstract] [Full Text] [Related]
7. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C
Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689
[TBL] [Abstract][Full Text] [Related]
8. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Non-Predominant-Lepidic Lung Adenocarcinoma Presenting as Ground Glass Opacity: Results of a Multicenter Study.
Messa F; Siciliani A; Piccioni G; Leonardi B; Ciccone AM; D'Andrilli A; Andreetti C; Menna C; Vanni C; Baccarini AE; Tiracorrendo M; Mancini M; Vecchione A; Nocera A; Calabrese G; Meacci E; Margaritora S; Natale G; Fiorelli A; Venuta F; Rendina EA; Maurizi G; Ibrahim M
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392586
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
[TBL] [Abstract][Full Text] [Related]
11. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
[TBL] [Abstract][Full Text] [Related]
12. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
13. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
Moon Y; Lee KY; Park JK
J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
[TBL] [Abstract][Full Text] [Related]
15. Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma.
Zhai WY; Wong WS; Duan FF; Liang DC; Gong L; Dai SQ; Wang JY
World J Oncol; 2022 Oct; 13(5):259-271. PubMed ID: 36406190
[TBL] [Abstract][Full Text] [Related]
16. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
17. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
[TBL] [Abstract][Full Text] [Related]
18. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
[TBL] [Abstract][Full Text] [Related]
19. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
